Literature DB >> 24522971

Non-apical positive surgical margins after radical prostatectomy for pT2 prostate cancer is associated with the highest risk of recurrence.

Martin Andreas Røder1, Sandra Kawa, Thomas Scheike, Birgitte Grønkaer Toft, Jacob Bjerg Hansen, Klaus Brasso, Ben Vainer, Peter Iversen.   

Abstract

BACKGROUND AND <br> OBJECTIVE: To investigate how location of positive surgical margins (PSM) in pT2 tumors affect the risk of biochemical recurrence (BR). <br> METHODS: The study includes 1,133 consecutive patients from 1995 until end of 2011, who had organ-confined disease (pT2) following RP. The location of PSM was stratified into apical and non-apical. BR was defined as the first PSA ≥ 0.2 ng/ml after RP. Risk of BR was analyzed with Kaplan-Meier and Cox regression analysis. <br> RESULTS: Median follow-up was 3.6 years (range: 0.5-15.5 years). The overall pT2 PSM rate was 26.3%. Overall, a pT2 with PSM had a 3.1-fold increased risk of BR compared to margin negative patients. Patients with pT2 apical and non-apical PSM had a 5-year biochemical recurrence-free survival of 84.9% (95% CI: 77.6-92.2%) and 78.6% (95% CI: 71.3-85.9%), respectively. In multivariate analysis, pT2 apical and non-apical PSM was individually associated with a 2.2- and 3.8-fold increased risk of BR compared to margin negative patients. <br> CONCLUSION: In our cohort the location of pT2 PSM was associated with time to BR, that is, patients with non-apical pT2 PSM endured the highest risk of BR compared to apical PSM. This may indicate that not all patients with pT2 PSM should be offered adjuvant therapy.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  biochemical recurrence; pT2 tumors; positive surgical margins; radical prostatectomy

Mesh:

Year:  2014        PMID: 24522971     DOI: 10.1002/jso.23573

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  3 in total

1.  Long-term oncological outcomes of apical positive surgical margins at radical prostatectomy in the Shared Equal Access Regional Cancer Hospital cohort.

Authors:  H Wadhwa; M K Terris; W J Aronson; C J Kane; C L Amling; M R Cooperberg; S J Freedland; M R Abern
Journal:  Prostate Cancer Prostatic Dis       Date:  2016-10-04       Impact factor: 5.554

2.  Biochemical recurrence of pathological T2+ localized prostate cancer after robotic-assisted radical prostatectomy: A 10-year surveillance.

Authors:  Che Hseuh Yang; Yi Sheng Lin; Yen Chuan Ou; Wei Chun Weng; Li Hua Huang; Chin Heng Lu; Chao Yu Hsu; Min Che Tung
Journal:  World J Clin Cases       Date:  2021-02-16       Impact factor: 1.337

3.  Robotic-assisted vs. open radical prostatectomy: an update to the never-ending debate.

Authors:  Thenappan Chandrasekar; Derya Tilki
Journal:  Transl Androl Urol       Date:  2018-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.